Taitra Innovation Hub
Company Overview

A Pioneer in Biomaterials for Regenerative Medicine

Website
Established in 2014, ACRO Biomedical Co., Ltd. is a biotechnology company focused on developing and manufacturing advanced biomaterial-based medical devices for tissue engineering and regenerative medicine. Utilizing proprietary supercritical carbon dioxide (scCO₂) extraction technology, ACRO Biomedical efficiently removes cells, lipids, and non-collagenous proteins from animal tissues while preserving natural collagen scaffolds. These high-quality biological scaffolds are applied in wound care, orthopedics, dentistry, ophthalmology, cardiovascular and neural surgery, and aesthetic microsurgery.
 
The company’s flagship product, ABCcolla® Collagen Ophthalmic Matrix, has been approved by Taiwan’s Ministry of Health and Welfare for ophthalmic use. To date, ACRO Biomedical holds 93 global patents and has received 42 medical device approvals across multiple countries, including the United States (FDA), India, Singapore, and several others—with international certifications continuously expanding.
 
Looking ahead, ACRO Biomedical is committed to advancing whole-organ engineering for heart, liver, and kidney applications by developing decellularized organ scaffolds for in vivo recellularization. Through continuous innovation and clinical application, the company aims to shape the future of regenerative medicine.
Image Description
Image Description

Making the Impossible Possible

ACRO Biomedical's vision is ambitious but clear: to tackle the global organ shortage with collagen scaffolds and organ engineering. Imagine a future where treatment doesn’t depend on donor waiting lists — but is accessible to everyone, everywhere.

Innovation for Vision Restoration

ABCcolla® Ophthalmic Matrix is an innovative solution that helps overcome long-standing challenges in eye surface regeneration.

ABCcolla® Collagen Matrix

BCcolla® Collagen Matrix is a sterile, bioresorbable collagen wound dressing made from porcine collagen using supercritical CO₂ decellularization. It preserves the natural triple-helix collagen structure to support cell proliferation, granulation, and epithelialization.

Key Features：
● Medical-grade collagen wound matrix with high porosity for exudate absorption and moist wound healing
● Flexible, easy to handle, and fully bioabsorbable within 7–14 days — no removal required
● Produced without crosslinking agents, ensuring safety and biocompatibility

Applications：
● Wound care products for chronic and acute wounds
● Collagen dressing for surgical sites, ulcers, and trauma care

Matrix

ABCcolla® Bone Graft

ABCcolla® Collagen Bone Graft is a decellularized porcine bone graft material prepared using supercritical CO₂ extraction. It is composed of native porcine collagen and bone matrix comparable to the human bone matrix.

Features：
● Designed for filling and augmentation of bone voids or gaps in orthopedic surgeries
● Facilitates cell attachment and supports bone regeneration
● Promotes neovascularization during healing
● Gradually resorbs and is replaced by new bone

Bone Graft

ABCcolla® ADM Scaffold

ABCcolla® ADM Scaffold is a decellularized porcine collagen dermal matrix developed with patented supercritical CO₂ technology.

Features：
● Absorbs wound exudates and maintains a moist healing environment
● Supports tissue regeneration during the healing process
● TFDA- and FDA 510(k)-approved for medical use
● Recipient of the 21st National Innovation Award for its micro-particle ADM application

ADM Scaffold
shutterstock_684989593

Get the Perfect Match

Start your 1-on-1 meetings with ACRO to explore new business opportunities. 

Trusted Certifications for Quality Assurance

DNV ISO13485

Stay Ahead of the Curve!

Subscribe Now for Exclusive Insights, Trends, and Offers Delivered Straight to Your Inbox!

Subscribe